Cargando…
Co-stimulatory agonists: An insight into the immunotherapy of cancer
Immune checkpoint pathways consist of stimulatory pathways, which can function like a strong impulse to promote T helper cells or killer CD8(+) cells activation and proliferation. On the other hand, inhibitory pathways keep self-tolerance of the immune response. Increasing immunological activity by...
Autores principales: | Pourakbari, Ramin, Hajizadeh, Farnaz, Parhizkar, Forough, Aghebati-Maleki, Ali, Mansouri, Sanaz, Aghebati-Maleki, Leili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278219/ https://www.ncbi.nlm.nih.gov/pubmed/34267616 http://dx.doi.org/10.17179/excli2021-3522 |
Ejemplares similares
-
Current applications and prospects of nanoparticles for antifungal drug delivery
por: Nami, Sanam, et al.
Publicado: (2021) -
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice
por: Daei Sorkhabi, Amin, et al.
Publicado: (2023) -
Current status of skin cancers with a focus on immunology and immunotherapy
por: Khayyati Kohnehshahri, Mahsa, et al.
Publicado: (2023) -
Cell-based therapy in thin endometrium and Asherman syndrome
por: Gharibeh, Nastaran, et al.
Publicado: (2022) -
Prognostic significance and therapeutic potentials of immune checkpoints in osteosarcoma
por: Meftahpour, Vafa, et al.
Publicado: (2022)